There was a significantly higher detection rate of CK20 mRNA in blood of patients with squamous cell carcinomas than with adenocarcinomas (45.71% versus 26.32%); however, this correlation was not significant (p = 0.084) (Table 3). This evidence concerns the gene KRT20 and adenocarcinoma.